Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-17 · accession 0001784606-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-19 | 2024-01-17 | JAZZ | Iannone Robert | EVP, Gbl Head of R, D | F - Tax | $119.13 | -1,730 | 49.6K | -3% | -$206.1K | |
| 2024-01-19 | 2024-01-17 | JAZZ | Iannone Robert | EVP, Gbl Head of R, D | A - Grant | $0.00 | +5,970 | 51.3K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-01-17 | F | D | 1,730 | $119.13 | 49,592 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-01-17 | A | A | 5,970 | $0.00 | 51,322 | D | — | — | (F2) The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023. |